Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-25 @ 2:11 AM
NCT ID:
NCT00962260
Eligibility Criteria:
Inclusion Criteria:
* Males and females, 18 years or older
* Diagnosis of Gaucher disease treated historically with imiglucerase
* Able to provide written informed consent
Exclusion Criteria:
* Currently taking another experimental drug for any condition
* History of allergy to carrots
* Previous infusion reaction suspected to be allergic in nature to Cerezyme® or Ceredase® or receiving premedication to prevent infusion reactions
* Allergy to beta-lactam antibiotics
* Presence of any medical, emotional, behavioral or psychological condition that in the judgment of the Investigator would interfere with the patient's compliance with the requirements of the study.
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00962260
Study Brief:
Protocol Section:
NCT00962260